Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-049516
Filing Date
2009-03-10
Accepted
2009-03-10 12:57:17
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 855272
2 EMPLOYEMENT OFFER LETTER dex1012.htm EX-10.12 17423
3 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1930
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1764
5 CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6792
6 CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6835
7 CERTIFICATION OF CEO, PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3681
8 CERTIFICATION OF CFO, PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3829
  Complete submission text file 0001193125-09-049516.txt   898927
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 09668593
SIC: 2834 Pharmaceutical Preparations